Fiduciary Family Office’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$367K Buy
4,310
+409
+10% +$36.5K 0.1% 138
2025
Q4
$308K Sell
3,901
-8,556
-69% -$671K 0.09% 139
2025
Q3
$996K Buy
12,457
+3,382
+37% +$288K 0.28% 69
2025
Q2
$825K Buy
9,075
+195
+2% +$17.8K 0.27% 72
2025
Q1
$832K Buy
+8,880
New +$795K 0.28% 77
2024
Q4
Sell
-6,780
Closed -$704K 111
2024
Q3
$704K Buy
+6,780
New +$691K 0.23% 93

Other funds holding CL

Fiduciary Family Office's CL Position: Q1 2026 in Review

Fiduciary Family Office increased its Colgate-Palmolive (CL) stake by 10% in Q1 2026, buying an estimated $36.5K and bringing the position to 4,310 shares worth $367K. The position accounts for 0.1% of the portfolio, ranked #138.

Fiduciary Family Office first reported a position in CL in Q3 2024 and has held it in 6 quarters since. The position peaked at $996K in Q3 2025. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Fiduciary Family Office held 4,310 shares of Colgate-Palmolive worth $367K as of Q1 2026.
  • Fiduciary Family Office bought 409 Colgate-Palmolive shares in Q1 2026, an estimated $36.5K.
  • Colgate-Palmolive made up 0.1% of Fiduciary Family Office's portfolio in Q1 2026, its #138 holding.
  • Fiduciary Family Office first reported a position in Colgate-Palmolive in Q3 2024 and has held it in 6 quarters since.
  • Fiduciary Family Office's Colgate-Palmolive position peaked at $996K in Q3 2025.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Fiduciary Family Office's 13F filing for Q1 2026, filed 14 May 2026.